Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AxoGen, Inc. (AXGN : NSDQ)
 
 • Company Description   
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.

Number of Employees: 451

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.40 Daily Weekly Monthly
20 Day Moving Average: 467,681 shares
Shares Outstanding: 41.98 (millions)
Market Capitalization: $394.62 (millions)
Beta: 0.75
52 Week High: $22.82
52 Week Low: $6.87
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 29.66% 41.53%
12 Week 27.20% 37.47%
Year To Date 0.32% 18.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
13631 PROGRESS BLVD. SUITE 400
-
ALACHUA,FL 32615
USA
ph: 386-462-6800
fax: 386-462-6801
investorrelations@axogeninc.com http://www.axogeninc.com
 
 • General Corporate Information   
Officers
Karen Zaderej - Chief Executive Officer; President and Chairman of
Peter J. Mariani - Executive Vice President and Chief Financial Offic
Quentin S. Blackford - Director
Gregory G. Freitag - Director
Mark Gold - Director

Peer Information
AxoGen, Inc. (ABMD)
AxoGen, Inc. (DMDS)
AxoGen, Inc. (CPWY.)
AxoGen, Inc. (EQUR)
AxoGen, Inc. (ECIA)
AxoGen, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 05463X106
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 41.98
Most Recent Split Date: 7.00 (1.05:1)
Beta: 0.75
Market Capitalization: $394.62 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.67 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.47
Price/Cash Flow: -
Price / Sales: 3.10
EPS Growth
vs. Year Ago Period: -73.33%
vs. Previous Quarter: -116.67%
Sales Growth
vs. Year Ago Period: -0.10%
vs. Previous Quarter: -1.68%
ROE
03/31/22 - -25.97
12/31/21 - -21.12
09/30/21 - -21.68
ROA
03/31/22 - -14.32
12/31/21 - -11.92
09/30/21 - -12.62
Current Ratio
03/31/22 - -
12/31/21 - 5.23
09/30/21 - 5.78
Quick Ratio
03/31/22 - -
12/31/21 - 4.54
09/30/21 - 5.12
Operating Margin
03/31/22 - -23.56
12/31/21 - -19.33
09/30/21 - -20.14
Net Margin
03/31/22 - -24.98
12/31/21 - -21.19
09/30/21 - -21.59
Pre-Tax Margin
03/31/22 - -
12/31/21 - -21.19
09/30/21 - -21.59
Book Value
03/31/22 - -
12/31/21 - 2.71
09/30/21 - 2.77
Inventory Turnover
03/31/22 - -
12/31/21 - 1.56
09/30/21 - 1.68
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.58
09/30/21 - 0.59
Debt-to-Capital
03/31/22 - -
12/31/21 - 36.83
09/30/21 - 36.93
 

Powered by Zacks Investment Research ©